Interprofessional Strategies for Mitigating Diagnostic and Treatment Delays in Patients With

Fibrosing ILDs

Education & Discussion Guides

View these video modules on important topics addressing the detrimental impact of diagnostic delays on disease progression, including screening, data and guidance of antifibrotic therapy, and multidisciplinary approaches to managing ILD. There are practical tools and patient cases featuring expert insights and discussion points that you can apply in your practice. Drive changes to positively impact care for your patients through prompt recognition and timely referral to specialized centers.

Do you want to bring this education to your team? Utilize the downloadable discussion guides and slide decks listed below the videos! An additional video on adult learning principles and presentation tips is provided to help you develop and lead sessions with your team.

Dr. Yoder outlines available guideline and diagnostic approaches to fibrosing ILD

Dr. Assassi discusses the risks of ILD in patients with SARDs

Dr. Assassi discusses screening for ILD in patients with SARDs

Dr. Yoder reviews available data and guidance of antifibrotic therapy for ILD

Dr. Assassi discusses guideline recommendations and treatment of SARD-ILD

Dr. Yoder discusses multidisciplinary approaches to managing ILD

Dr. Yoder discusses monitoring and interpretation of lung function testing in a patient with myositis

Dr. Assassi reviews the diagnosis and lung function monitoring of a patient with SSc

Get tips to help deliver compelling education to your team and other audiences

Interested in participating in a digital quality improvement program? Think quality improvement is only possible in large, well-resourced hospital systems? The education and practical tools in this activity are also part of a scalable and customizable digital improvement program that was designed for efficient use in clinical practices of all sizes. Complete an assessment to identify how your processes align with pre-identified performance measures and then use the system to dynamically identify goals and create an action plan for improvement. Return 30+ days later and complete a reassessment. It’s that simple.

Hear from faculty on why QI is essential for impactful care of patients with Fibrosing ILDs:

You don’t realize what you’re doing right and what you’re doing wrong without measuring or assessing them. The process of going through a quality improvement program is that it makes you ask yourselves the right questions, some of which you might not have been thinking about, and seeing how you are doing with them. - Mark Yoder, MD

Each practice has its unique characteristics and has its own challenges in terms of early diagnosis or monitoring, or treatment of ILDs. This program allows clinicians to identity those unique areas that need to be improved so that clinical practice becomes more aligned with published guidelines. - Shervin Assassi, MD, MS